MeshFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « MeshFr.i » - entrée « Réplication virale »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Répartition par âge < Réplication virale < Réponse aux protéines mal repliées  Facettes :

List of bibliographic references indexed by Réplication virale

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000019 (2020) Annie Ladoux [France] ; Stéphane Azoulay [France] ; Christian Dani [France][SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
000069 (2020) Sara Salinas [France] ; Yannick Simonin [France][Neurological damage linked to coronaviruses : SARS-CoV-2 and other human coronaviruses].
000204 (2020) V. Bonny [France] ; A. Maillard [France] ; C. Mousseaux [France] ; L. Plaçais [France] ; Q. Richier [France][COVID-19: Pathogenesis of a multi-faceted disease].
000268 (2020) Zhenlin Li [France] ; Denise Paulin [France] ; Patrick Lacolley [France] ; Dario Coletti [France, Italie] ; Onnik Agbulut [France]Vimentin as a target for the treatment of COVID-19.
000419 (2020) María Moriel-Carretero [France]The hypothetical role of phosphatidic acid in subverting ER membranes during SARS-CoV infection.
000428 (2020) Laure Perrin-Cocon [France] ; Olivier Diaz [France] ; Clémence Jacquemin [France] ; Valentine Barthel [France] ; Eva Ogire [France] ; Christophe Ramière [France] ; Patrice André [France] ; Vincent Lotteau [France] ; Pierre-Olivier Vidalain [France]The current landscape of coronavirus-host protein-protein interactions.
000700 (2020) Daria Sicari [France, Italie] ; Aristotelis Chatziioannou [Grèce] ; Theodoros Koutsandreas [Grèce] ; Roberto Sitia [Italie] ; Eric Chevet [France, Italie]Role of the early secretory pathway in SARS-CoV-2 infection.
000981 (2020) Olivier Garraud [France]Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
000996 (2020) Amélie Soumier [France] ; Angela Sirigu [France]Oxytocin as a potential defence against Covid-19?
000A15 (2020) Allan Sauvat [France] ; Fabiola Ciccosanti [Italie] ; Francesca Colavita [Italie] ; Martina Di Rienzo [Italie] ; Concetta Castilletti [Italie] ; Maria Rosaria Capobianchi [Italie] ; Oliver Kepp [France] ; Laurence Zitvogel [France, République populaire de Chine] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède]On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.
000B90 (2020) Rami Bou Khalil [Liban]Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
000C75 (2020) Laurent Softic [France] ; Rozenn Brillet [France] ; François Berry [France] ; Nazim Ahnou [France] ; Quentin Nevers [France] ; Margot Morin-Dewaele [France] ; Sabah Hamadat [France] ; Patrice Bruscella [France] ; Slim Fourati [France] ; Jean-Michel Pawlotsky [France] ; Abdelhakim Ahmed-Belkacem [France]Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
000C99 (2020) Julien Andreani [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Priscilla Jardot [France] ; Clara Rolland [France] ; Manon Boxberger [France] ; Nathalie Wurtz [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Didier Raoult [France]In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect.
000D00 (2020) Franck Touret [France] ; Magali Gilles [France] ; Karine Barral [France] ; Antoine Nougairède [France] ; Jacques Van Helden [France] ; Etienne Decroly [France] ; Xavier De Lamballerie [France] ; Bruno Coutard [France]In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
000D02 (2020) T. Joshi [Inde] ; T. Joshi ; P. Sharma ; S. Mathpal ; H. Pundir ; V. Bhatt ; S. ChandraIn silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.
001158 (2020) Grégorie Lebeau [France] ; Damien Vagner [France] ; Étienne Frumence [France] ; Franck Ah-Pine [France] ; Xavier Guillot [France] ; Estelle Nobécourt [France] ; Loïc Raffray [France] ; Philippe Gasque [France]Deciphering SARS-CoV-2 Virologic and Immunologic Features.
001236 (2020) Fran Robson [Royaume-Uni] ; Khadija Shahed Khan [Hong Kong] ; Thi Khanh Le [France] ; Clément Paris [France] ; Sinem Demirbag [Turquie] ; Peter Barfuss [France] ; Palma Rocchi [France] ; Wai-Lung Ng [Hong Kong]Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.
001625 (2020) Vincent Gies [France] ; Nassima Bekaddour [France] ; Yannick Dieudonné [France] ; Aurélien Guffroy [France] ; Quentin Frenger [France] ; Frédéric Gros [France] ; Mathieu Paul Rodero [France] ; Jean-Philippe Herbeuval [France] ; Anne-Sophie Korganow [France]Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Réplication virale" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Réplication virale" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Réplication virale
}}
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021